SYNAPSE BIOMEDICAL INC

OBERLIN, OH · CIK 0001273829 · Medtech · Private

Neurostimulator devices for therapeutic applications

synapsebiomedical.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$433K
2 Form D · Dec 2022
45 months since last filing
Contracts
$136K
10 awards · Veterans Affairs
#495 of 4531 in medtech
Patents
12
3 granted · 9 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal contractDepartment of Veterans Affairs · Neurocontrol Model$25,015
Federal contractDepartment of Veterans Affairs · Miscellaneous$5,020
Private capital raisedForm D · SEC$433,358
Federal contractDepartment of Veterans Affairs · Research Biopolar Permaloc Electrodes$6,745
Federal contractDepartment of Veterans Affairs · Medical, Dental&veterinary Eqip$6,720
Federal contractDepartment of Veterans Affairs · 12 Channel Stimulator$33,000
Federal contractDepartment of Veterans Affairs · Synapse Permaloc System$28,100
Federal contractDepartment of Veterans Affairs · Purchase 15 Permaloc Electrodes$4,799
Federal contractDepartment of Veterans Affairs · Electrodes$3,150
Private capital raisedForm D · SEC$809,998
Federal contractDepartment of Veterans Affairs · Prosthetics:external Pulse Generator$11,699
Federal contractDepartment of Veterans Affairs · Surgical Implant$11,845
Federal contract · USAspendingForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
492CND LIFE SCIENCES, INC.$146K$19M
493Vicis, Inc.$141K$67M
494SOMARK INNOVATIONS INC$140K$300K
495SYNAPSE BIOMEDICAL INC$136K$433K
496GRAYMATTER RESEARCH$135K—
497Wang Nmr Inc.$135K—
498CERAPEDICS INC$133K$92M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 8 related persons
  • Sungho ChoDirector
  • Moustapha DiopDirector · Executive Officer
  • Edgar EnglemanDirector
  • Anthony IgnagniDirector · Executive Officer
  • John KrystowskiDirector
  • Kiyotaka MoriDirector
  • Raymond OndersDirector
  • Louis TabickmanDirector

Patents

USPTO · 3 granted of 12

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.